Streetbeat News

Analyst Ratings

UNCY

EF Hutton analyst Elemer Piros has reiterated a 'Buy' rating on Unicycive Therapeutics (NASDAQ:UNCY) and maintained a $5 price target.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 11:07 am

AMZN

NKE

NVDA

The S&P 500 settled higher on Thursday, driven by a rally in bank stocks following positive Fed stress test results. The U.S. economy expanded by an annualized rate of 2% in Q1, exceeding market expectations. Traders anticipate a 87% chance of a 25 basis point rate hike by the Federal Reserve in July. NIKE reported lower than expected Q4 earnings, while NVIDIA and Amazon shares fell, contributing to a 0.16% drop in the Nasdaq 100.

Portfolio Pulse from Lisa Levin

June 30, 2023 | 11:05 am

XPEV

XPeng's stock has been upgraded from Buy to Outperform by CLSA, with the price target raised from $10 to $13.1. This has resulted in XPeng shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 11:02 am

SGH

Rosenblatt analyst Kevin Cassidy has reiterated a 'Buy' rating on SMART Global Holdings (NASDAQ:SGH) and maintained a price target of $35.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 11:01 am

CCL

CUK

Carnival Corporation's shares are trading higher following an upgrade from Jefferies, which changed its rating from 'Hold' to 'Buy' and increased the price target from $9 to $25.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 11:00 am

CCL

NKE

QQQ

SPY

US stocks are set to finish the first half of the year on a high note, with bullish momentum expected to continue into the second half. The S&P 500 Index and the Dow Industrials ended Thursday's session moderately higher, while the Nasdaq Composite remained flat. Small-caps outperformed for a fourth straight session. In premarket trading on Friday, the SPDR S&P 500 ETF Trust (NYSE:SPY) rose 0.39% and the Invesco QQQ ETF (NASDAQ:QQQ) gained 0.49%. Nike (NYSE:NKE) fell over 3% in premarket trading following below-consensus quarterly results, while Carnival Corp. (NYSE:CCL) climbed over 3% after an upgrade from Jefferies.

Portfolio Pulse from Shanthi Rexaline

June 30, 2023 | 10:48 am

PIII

TD Cowen analyst Gary Taylor has initiated coverage on P3 Health Partners (NASDAQ:PIII) with a Market Perform rating.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 10:44 am

KYMR

Truist Securities analyst Srikripa Devarakonda has initiated coverage on Kymera Therapeutics (NASDAQ:KYMR) with a Buy rating and a price target of $50.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 10:42 am

USPH

B of A Securities analyst Joanna Gajuk has initiated coverage on US Physical Therapy (NYSE:USPH) with a Buy rating and a price target of $138.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 10:41 am

CLB

Citigroup analyst Scott Gruber has downgraded Core Laboratories (NYSE:CLB) from Neutral to Sell and lowered the price target from $22 to $21.

Portfolio Pulse from richadhand@benzinga.com

June 30, 2023 | 10:39 am